Q: If the attending documented, "likely mixed cardiogenic and septic shock," can I assign codes R57.0 and R65.21?
A: Refer to the documentation within the code book. If you open the book to the R57 code grouping (Shock not elsewhere classified) listed below there is an Excludes1 note. Remember, Excludes 1 notes instruct us that we cannot use codes from this grouping with those listed within the Excludes 1 note. Cardiogenic shock (R57.2) falls within this grouping. Also listed is R65.2 septic shock. Purely relying on the coding conventions, I would conclude that we cannot code septic shock with cardiogenic shock. See the image below.
But, there is more to consider. AHA Coding Clinic-for ICD-10-CM/PCS, Fourth Quarter, 2015.
"There are circumstances that have been identified where some conditions included in Excludes 1 notes should be coded, and thus might be more appropriate for an Excludes 2 note.
The new guidelines concerning Excludes 1 notes is intended to allow conditions to be reported together when appropriate even though they may currently be subject to an Excludes 1 note."
So, does the situation you describe allow for us to code both types of shock? To adequately answer this, we would need to delve into the record a bit deeper. To override the Excludes 1 note, the documentation would need to explicitly state there was both an infectious cause of hypoperfusion at the chemical/cellular level AND a mechanical pump failure causing reduced hemodynamic performance (but it doesn't have to be in those exact words as long as the evidence is within the record and the doctor provided both diagnoses). You do have the statement from the provider that the shock was of multiple etiologies and this is supportive of reporting both codes. I would like to see treatment protocols that support the treatment of both etiologies documented in the record as well.
This would be a great discussion for you to investigate with your coding team to ensure you are providing them the appropriate documentation to capture the severity of the patient's conditions.
Editor's Note: Laurie L. Prescott, RN, MSN, CCDS, CDIP, CDI Education Specialist at HCPro in Danvers, Massachusetts, answered this question. Contact her at firstname.lastname@example.org.
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
If you are not seeing a CCI edit when reporting an E/M code with a certain procedure, it may be that there is no edit. CMS does not have a CCI edit for every CPT code, however, there are still general coding rules that must be followed.
The use of Modifier 25 is one example ...
To determine the dosage, size, doses per package and how many billing units are in each package, refer to the NDC number.
Take a look at the following
J1071 - Injection, testosterone cypionate, 1mg
For example; using NCD # 0009-0085-10 there are 10 doses of 100 mL
(100 mg/mL = 1 mL and there are ...
As we begin returning back to work, we will all face a new normal. The COVID-19 pandemic has changed the face of business. While it has certainly been a challenge to keep up with the ever-changing regulations (that’s likely to continue for a little longer), exciting new opportunities have also been created, such as the expansion of telemedicine. There’s also the maze of government funding that needs to be navigated and an increased awareness of OSHA standards to implement.
The CDC has released additional information and coding guidance for reporting encounters related to the 2019 health care encounters and deaths related to e-cigarette, or vaping, product use associated lung injury (EVALI).
The update offers coding scenarios for general guidance, poisoning and toxicity, substance abuse and signs and symptoms.
ICD-10-CM Official Coding Guidelines - ...
On April 30, 2020, CMS announced additional sweeping changes to meet the challenges of providing adequate healthcare during this pandemic. These changes expand the March 31st changes. The article covers some of the key changes. See the official announcement in the references below.
Risk adjustment is simply a way of making sure that there are sufficient funds to adequately take care of the healthcare needs of a certain population. It’s a predictive modeling methodology based on the diagnoses of the individuals in that population. As payers move to value based models, they heavily rely on risk adjustment to ensure proper funding.
All healthcare providers who are currently participating in the MIPS portion of Medicare’s Quality Payment Program may want to participate in the new COVID-19 Clinical Trials improvement activity. Read more about it here.